Downloads
Offline medicines formulary and clinical drug reference with full-text search.
About MediWiZ
MediWiZ is an education app developed by WiZmed.
Download Statistics
MediWiZ has been downloaded 10 times. In the last 30 days, the app was downloaded 5 times.
User Ratings
The app has no ratings yet.
App Information
MediWiZ is FREE to download. The APK download size is 88.04 MB. The latest version available is 1.0. The last update was on July 10, 2026.
Technical Requirements
The app has a content rating of Everyone. The app has been available on Google Play July 2026.
More data about MediWiZ
| Price | Free to download |
| Total downloads | 10 |
| Recent downloads | 5 |
| Rating | No ratings |
| Ranking | Not ranked |
| Version | 1.0 |
| APK size | 88.0 MB |
| Number of libraries | ? |
| Suitable for | Everyone |
| Ads | NO ads |
App Performance Report
Get a detailed PDF report for MediWiZ with download trends, rating history, and key performance statistics — useful for competitive research or tracking your own app. Learn more
Get PDF Report — $29Alternative downloads for the MediWiZ app
MediWiZ compared with similar apps
Common keywords of similar apps
Mediwiz Formulary Full Prescribing Product Offline Text Healthcare Monograph Fully Atc Therapeutic Instantly Chapter Additional Searchable Branded Icd Find Decisions Clinical Drug Reference Medicines Search Professionals Monographs Information Content Guidelines Tools Trade App
Keywords missing from this app
Patient Drugs Medical Subscription Free Care Safety Generic Access Medication Medications Nurses Guide Medicine Auto Purchase Including Comprehensive Administration Nursing Recent Support Considerations Features Interactions Health Includes Trial Iv Terms Edition Trusted Latest Current Dental Date Dosing
More from WiZmed
Downloads over time
MediWiZ has been downloaded 10 times. Over the past 30 days, it has been downloaded 5 times.
Changelog of MediWiZ
Developer information for WiZmed
Comments on MediWiZ for Android
We don't have enough comments to show example comments. Please check back later.